JPS60258195A - α．α―トレハロース脂肪酸ジエステル誘導体 - Google Patents

α．α―トレハロース脂肪酸ジエステル誘導体

Info

Publication number
JPS60258195A
JPS60258195A JP59115204A JP11520484A JPS60258195A JP S60258195 A JPS60258195 A JP S60258195A JP 59115204 A JP59115204 A JP 59115204A JP 11520484 A JP11520484 A JP 11520484A JP S60258195 A JPS60258195 A JP S60258195A
Authority
JP
Japan
Prior art keywords
formula
benzyl
alpha
trehalose
tetra
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59115204A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0528239B2 (2
Inventor
Yoshihiro Nishikawa
西川　嘉廣
Kimihiro Kanemitsu
金光　公浩
Tatsuhiko Katori
香取　達彦
Akihiro Shibata
柴田　晶弘
Kenichi Kukita
茎田　憲一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Priority to JP59115204A priority Critical patent/JPS60258195A/ja
Priority to US06/734,198 priority patent/US4684719A/en
Priority to GB08512461A priority patent/GB2160518B/en
Priority to CA000482062A priority patent/CA1236831A/en
Priority to DE19853518638 priority patent/DE3518638A1/de
Priority to IT48162/85A priority patent/IT1182732B/it
Priority to FR858508445A priority patent/FR2565232B1/fr
Priority to CH2384/85A priority patent/CH666042A5/de
Publication of JPS60258195A publication Critical patent/JPS60258195A/ja
Publication of JPH0528239B2 publication Critical patent/JPH0528239B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
JP59115204A 1984-06-05 1984-06-05 α．α―トレハロース脂肪酸ジエステル誘導体 Granted JPS60258195A (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP59115204A JPS60258195A (ja) 1984-06-05 1984-06-05 α．α―トレハロース脂肪酸ジエステル誘導体
US06/734,198 US4684719A (en) 1984-06-05 1985-05-15 α,α-trehalose fatty acid diester derivative
GB08512461A GB2160518B (en) 1984-06-05 1985-05-16 A,a-trehalose 4,4' diesters
CA000482062A CA1236831A (en) 1984-06-05 1985-05-22 .alpha.,.alpha.-TREHALOSE FATTY ACID DIESTER DERIVATIVE AND PREPARATION PROCESS THEREOF
DE19853518638 DE3518638A1 (de) 1984-06-05 1985-05-23 (alpha),(alpha)-trehalose-fettsaeurediesterderivate und verfahren zu deren herstellung
IT48162/85A IT1182732B (it) 1984-06-05 1985-06-04 Derivato di diestere di acido grasso alpha, alpha-trealosio e procedimento per prepararlo
FR858508445A FR2565232B1 (fr) 1984-06-05 1985-06-05 Nouveaux diesters d'acides gras et d'a,a-trehalose, leur procede de preparation et leur application en therapeutique
CH2384/85A CH666042A5 (de) 1984-06-05 1985-06-05 Alpha,alpha-trehalose-fettsaeurediester-derivate und ihre herstellung.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59115204A JPS60258195A (ja) 1984-06-05 1984-06-05 α．α―トレハロース脂肪酸ジエステル誘導体

Publications (2)

Publication Number Publication Date
JPS60258195A true JPS60258195A (ja) 1985-12-20
JPH0528239B2 JPH0528239B2 (2) 1993-04-23

Family

ID=14656930

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59115204A Granted JPS60258195A (ja) 1984-06-05 1984-06-05 α．α―トレハロース脂肪酸ジエステル誘導体

Country Status (8)

Country Link
US (1) US4684719A (2)
JP (1) JPS60258195A (2)
CA (1) CA1236831A (2)
CH (1) CH666042A5 (2)
DE (1) DE3518638A1 (2)
FR (1) FR2565232B1 (2)
GB (1) GB2160518B (2)
IT (1) IT1182732B (2)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62117764A (ja) * 1985-11-18 1987-05-29 Mitsubishi Electric Corp サ−マルヘツド
US6497898B1 (en) 1993-10-07 2002-12-24 Kanebo Ltd Surfactant, and an emulsion-type cosmetic composition and a lipsome containing said surfactant
WO2007063902A1 (ja) * 2005-11-30 2007-06-07 The Nisshin Oillio Group, Ltd. トレハロース脂肪酸エステル組成物

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62174094A (ja) * 1985-12-16 1987-07-30 Ss Pharmaceut Co Ltd α．α―トレハロース誘導体
US5006514A (en) * 1986-03-20 1991-04-09 Sawai Pharmaceutical Co., Ltd. α,α-trehalose trimycolates and pharmaceutical compositions
DE3825678A1 (de) * 1988-07-28 1990-02-01 Wacker Chemie Gmbh Reinigungs- und/oder konditioniermittel fuer glaskeramikoberflaechen, enthaltend organopolysiloxane
US5049664A (en) * 1988-08-26 1991-09-17 Sawai Pharmaceutical Co., Ltd. Trehalose derivatives
ES2179831T3 (es) 1992-09-29 2003-02-01 Inhale Therapeutic Syst Liberacion en los pulmones de fragmentos activos de hormona paratiroidiana.
NZ281112A (en) 1994-03-07 1998-04-27 Inhale Therapeutic Syst Powdered insulin delivered as an aerosol
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6964771B1 (en) * 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
ES2525087T5 (es) 2000-05-10 2018-06-28 Novartis Ag Polvos basados en fosfolípidos para administración de fármacos
GB0027659D0 (en) * 2000-11-13 2000-12-27 Imerys Minerals Ltd Grinding of particulate material
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
EP2172263A4 (en) * 2007-07-02 2015-08-05 Nisshin Oillio Group Ltd E / H / E EMULSION COMPOSITION
WO2019197595A2 (en) 2018-04-13 2019-10-17 Glaxosmithkline Biologicals Sa Compounds and uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE549741A (2) *
US4491659A (en) * 1981-03-30 1985-01-01 Merck & Co., Inc. 2,6-Didioxy-3-amine,4-carboxy methylglycoside and related compounds

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62117764A (ja) * 1985-11-18 1987-05-29 Mitsubishi Electric Corp サ−マルヘツド
US6497898B1 (en) 1993-10-07 2002-12-24 Kanebo Ltd Surfactant, and an emulsion-type cosmetic composition and a lipsome containing said surfactant
WO2007063902A1 (ja) * 2005-11-30 2007-06-07 The Nisshin Oillio Group, Ltd. トレハロース脂肪酸エステル組成物
US7956181B2 (en) 2005-11-30 2011-06-07 The Nisshin Oillio Group, Ltd. Trehalose fatty acid ester composition
JP5192804B2 (ja) * 2005-11-30 2013-05-08 日清オイリオグループ株式会社 トレハロース脂肪酸エステル組成物

Also Published As

Publication number Publication date
JPH0528239B2 (2) 1993-04-23
GB8512461D0 (en) 1985-06-19
IT8548162A0 (it) 1985-06-04
US4684719A (en) 1987-08-04
IT1182732B (it) 1987-10-05
GB2160518B (en) 1987-07-29
FR2565232B1 (fr) 1989-05-19
CA1236831A (en) 1988-05-17
GB2160518A (en) 1985-12-24
CH666042A5 (de) 1988-06-30
FR2565232A1 (fr) 1985-12-06
DE3518638A1 (de) 1985-12-19

Similar Documents

Publication Publication Date Title
JPS60258195A (ja) α．α―トレハロース脂肪酸ジエステル誘導体
AU2020201369A1 (en) Synthesis of polycyclic-carbamoylpyridone compounds
US3078214A (en) Treatment of mental disturbances with esters of indoles
GB1563398A (en) 4-(alkoxyphenyo)-2-pyrrolidones
JPS61155358A (ja) ジアリール酪酸誘導体
US3903137A (en) Choline sulfonate derivatives
EP0797564A1 (en) Lignans, a process for their production and pharmaceutical compositions and uses thereof
JP3040182B2 (ja) イミダゾピリダジン誘導体、その用途及び製造法
SU841589A3 (ru) Способ получени гексагидро- - КАРбОлиНОВ или иХ СОлЕй
Lee et al. Antitumor agents. 86. Synthesis and cytotoxicity of. alpha.-methylene-. gamma.-lactone-bearing purines
JPH0635458B2 (ja) ピリドンカルボン酸誘導体、そのエステルおよびその塩
SU1258325A3 (ru) Способ получени производных @ -фталидил-5-фторурацила
EP4163280A1 (en) Method for producing heterocyclic compound
JPS6130588A (ja) ベンゾ〔ｃ〕〔１，８〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤
CN113549040A (zh) 一种吗替麦考酚酯杂质d的制备方法
CN115716817B (zh) 6,8-环三硫辛酸的制备方法
JPS632274B2 (2)
CN114437102B (zh) 一种新型的冬凌草甲素去6位羟基衍生物、其制备方法及医药用途
JP2710052B2 (ja) コードファクター関連化合物及びその製造法並びに該化合物を含有する免疫増強剤
EP0049144B1 (en) 5-fluoro uracil derivatives
US3855205A (en) Process for preparing adenosine-5{40 -carboxylates
JPH0558956A (ja) ２−シクロペンテン−１−オン誘導体及び制癌剤
JP4366499B2 (ja) 環状エーテルアミン誘導体
JPH10505331A (ja) ベンジルイミダゾピリジン
JP2989865B2 (ja) ピロロキノリン誘導体、そのエステルおよびその塩